關鍵數據
84.260今開
85.610最高
789.61K成交量
41.47本益比TTM
16.23本益比動
--股利TTM
1.74%換手率
84.820昨收
82.750最低
38.43M成交額
23.09本益比靜
4.86市淨率
0.00%股息率 TTM
4.02%ROA
87.32052週最高
1.03量比
167.68M淨利潤
45.25M總股本
2.0625每股盈餘TTM
0.55Beta
12.03%ROE
47.31552週最低
3.37%振幅
54.22%毛利率
3.87B總市值
4.73回報/風險
2.76%風險率
操作建議
Haemonetics Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名33/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為90.78。中期看,股價處於上升通道。近一個月,市場表現較強,基本面評分較高,但較強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Haemonetics Corp新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Haemonetics Corp簡介
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
公司代碼HAE
公司Haemonetics Corp
CEOSimon (Christopher A)
網址https://www.haemonetics.com
公司股東
常見問題
Haemonetics Corp(HAE)的當前股價是多少?
Haemonetics Corp(HAE)的當前股價是 85.54。
Haemonetics Corp 的股票代碼是什麼?
Haemonetics Corp的股票代碼是HAE。
Haemonetics Corp股票的52週最高點是多少?
Haemonetics Corp股票的52週最高點是87.32。
Haemonetics Corp股票的52週最低點是多少?
Haemonetics Corp股票的52週最低點是47.31。
Haemonetics Corp的市值是3.87B。
現在Haemonetics Corp(HAE)的股票是買入、持有還是賣出?
根據分析師評級,Haemonetics Corp(HAE)的總體評級為買入,目標價格為90.78。
Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是多少
Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是2.06。